Improving care for hospitalized patients with Lewy body disorders at the end of life
Improving End-of-Life Care for Hospitalized Patients with Lewy Body Disorders
This study is looking to improve the care for people with Lewy body disorders, a type of Alzheimer's disease, by finding better ways to predict their needs and ensure they receive the kind of support they want during their last months in the hospital.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10866125 on NIH RePORTER |
What this research studies
This research focuses on enhancing the quality of end-of-life care for patients with Lewy body disorders, which are a type of Alzheimer's disease. It aims to address significant gaps in understanding how to predict mortality and assess the quality of care these patients receive while hospitalized. By developing a prognostic model and a tool to measure care quality, the project seeks to ensure that treatment aligns with patient preferences during their final months. The research will involve collaboration with healthcare professionals to implement these improvements in acute care settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are hospitalized patients diagnosed with Lewy body disorders or related dementias.
Not a fit: Patients with Lewy body disorders who are not hospitalized or those in the early stages of the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better end-of-life care that aligns with the wishes of patients suffering from Lewy body disorders.
How similar studies have performed: Previous research has shown that improving end-of-life care for neurodegenerative disorders can lead to better patient outcomes, indicating that this approach has potential for success.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Aamodt, Whitley — University of Pennsylvania
- Study coordinator: Aamodt, Whitley
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.